Provided by Tiger Fintech (Singapore) Pte. Ltd.

American Tower

229.87
-1.3700-0.59%
Post-market: 229.870.00000.00%19:33 EDT
Volume:1.03M
Turnover:236.77M
Market Cap:107.61B
PE:59.02
High:231.55
Open:230.62
Low:228.25
Close:231.24
Loading ...

American Tower REIT Raised to Overweight From Equal-Weight by Morgan Stanley

Dow Jones
·
02 Apr

American Tower assumed at Overweight from Equal Weight at Morgan Stanley

TIPRANKS
·
01 Apr

American Tower assumed with an Overweight at Morgan Stanley

TIPRANKS
·
01 Apr

Jim Cramer Calls American Tower (AMT) a Diversity Paragon – Cell Towers Stand Strong!

Insider Monkey
·
31 Mar

Is American Tower Corporation (AMT) the Top Stock to Buy According to Akre Capital Management?

Insider Monkey
·
30 Mar

American Tower REIT Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
28 Mar

American Tower (AMT) Gets a Buy from Citi

TIPRANKS
·
27 Mar

American Tower REIT Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
25 Mar

Zscaler, Rocket Lab, American Tower, Intuit, and Zomedica: Insider Moves Unveiled!

TIPRANKS
·
22 Mar

American Tower REIT Is Maintained at Overweight by Barclays

Dow Jones
·
22 Mar

Barclays Adjusts Price Target on American Tower to $223 From $214, Maintains Overweight Rating

MT Newswires Live
·
21 Mar

American Tower (AMT) Gets a Buy from Barclays

TIPRANKS
·
21 Mar

U.S. tower stock valuations refreshed at MoffettNathanson

Investing.com
·
20 Mar

MoffettNathanson Adjusts Price Target on American Tower to $239 From $206, Keeps Buy Rating

MT Newswires Live
·
20 Mar

Top Executive Sells Thousands of American Tower Shares

TIPRANKS
·
20 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Blackstone, PepsiCo, Blue Owl Capital

Reuters
·
18 Mar

BUZZ-Wells Fargo upgrades American Tower and Crown Castle on improving market conditions

Reuters
·
17 Mar

W.P. Carey Cheers Investors With Dividend Hike: Is It Sustainable?

Zacks
·
17 Mar

American Tower REIT Raised to Overweight From Equal-Weight by Wells Fargo

Dow Jones
·
17 Mar

Beat the Market the Zacks Way: Amgen, DRDGOLD, Anavex in Focus

Zacks
·
17 Mar